Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Serum Pentraxin 3 and High Sensitive CRP in Female Patients With Gestational Diabetes Mellitus in Second Trimester of Pregnancy.

NCT05846191 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05846191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05846191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Serum Pentraxin 3 and High Sensitive CRP in Female Patients With Gestational Diabetes Mellitus in Second Trimester of Pregnancy.
Lead sponsor
Assiut University
Phase
Not applicable
Overall status
Unknown status
Start date
December 5, 2023
Completion date
March 10, 2025
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes mellitus in second trimester of pregnancy